29 Nov, 2012
Monoclonal antibody to glycated hemoglobin (HbA1c)
Diabetes causes substantial health costs because of complications associated with it and therefore repeated glucose measurements are an essential part of diabetes daily care.
Читать дальше
22 May, 2012
HyTest excellent half year growth
Year to year revenue growth was 18%. Hytest profitability continues to be on high level even though HyTest has been investing to China operations and IP-portfolio amongst other things.
Читать дальше
22 Jun, 2011
HyTest abstract has won National Academy of Clinical Biochemistry Distinguished Abstract Award
HyTest attends to AACC 2011 Clinical Expo in Atlanta, July 25-28. You are warmly welcome to visit our booth #27 at any time.
Читать дальше
15 Feb, 2011
Licensing opportunities – technology solution for BNP- and proBNP -detection
Interested in entering the fast growing cardiac diagnostics market with a new innovative diagnostics solution?
Читать дальше
06 Feb, 2011
Strong growth of HyTest continues – revenue almost 10 million euros
HyTest revenue increased by 17% to 9.1 million euros and the operating profit was 3.1 million euros and in percentage 34%.
Читать дальше
18 May, 2010
D-dimer and High Molecular Weight Fibrin Degradation
HyTest offers D-dimer produced from clotted fibrinogen by means of plasmin digestion and anti-D-dimer MAbs.
Читать дальше
16 Apr, 2010
Antibodies for New Type of BNP immunoassay – “Single Epitope Sandwich” assay
HyTest specialists have recently developed antibodies for a brand new type of BNP immunoassay
Читать дальше
Чтобы быть в курсе новых продуктов и научных открытий

Спасибо Вам за подписку!